USP21 and urinary bladder carcinoma: Notably, 20-hydroxyecdysone (20-HE) can directly inhibit NF-κB/p65 signaling at the transcriptional level while also serving as an inhibitor of USP21, leading to p65 protein degradation and the blockade of its activation, ultimately preventing the progression of bladder cancer (Ma et al., 2024).